Ascendis Pharma A/S (Nasdaq: ASND) today announced that it has called all $575.0 million aggregate principal amount of its outstanding 2.25% Convertible Senior Notes due 2028 (the “notes”) (CUSIP No.

Top investment options 2026: Compare fixed deposits, PPF, mutual funds, ELSS, and gold to balance risk, returns, and ...

Well-written multiple-choice items can deepen thinking and learning, rather than simply challenging students to recall basic ...

At $630, this new breed of Kindle is expensive, but its sleek build, color panel, and paper-like display surface are the core reasons to buy it, if you can stick with the basics.

Review Ever since AMD's cache-stacked Ryzen 7 5800X3D closed the gap with Intel in gaming, folks have wondered: if one ...

The smart-glasses project sits inside a much larger S&T biometric portfolio. In the Border Security and Immigration section ...

Add-on Revenue -- Increased 67% year over year in Q4, supported by new features such as back-in-stock notifications and ...

GAAP basis, income from operations was USD 25.1 million, while net income attributable to TAL reached USD 42 million. Now, ...

From recovery protocols and nutrition to purpose and mental resilience, these books deliver actionable frameworks ...

Jessica Rendall is a reporter with experience covering a variety of health and wellness topics, including chronic disease, ...

At this time, I would like to welcome everyone to the Manhattan Associates First Quarter 2026 Earnings Conference Call. [Operator Instructions] And as a reminder, ladies and gentlemen, this call is ...

Welcome to the 3M First Quarter Earnings Conference Call. [Operator Instructions] As a reminder, this call is being recorded, Tuesday, April 21, 2026. I would now like to turn the call over to Chinmay ...